Investment Research Partners LLC Makes New Investment in Mettler-Toledo International, Inc. $MTD

Investment Research Partners LLC purchased a new position in Mettler-Toledo International, Inc. (NYSE:MTD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 533 shares of the medical instruments supplier’s stock, valued at approximately $654,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MTD. Geneos Wealth Management Inc. raised its position in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 30 shares during the period. Creative Planning boosted its holdings in Mettler-Toledo International by 24.5% in the 2nd quarter. Creative Planning now owns 3,574 shares of the medical instruments supplier’s stock worth $4,198,000 after buying an additional 703 shares during the period. Cetera Investment Advisers increased its stake in Mettler-Toledo International by 8.4% in the 2nd quarter. Cetera Investment Advisers now owns 1,335 shares of the medical instruments supplier’s stock worth $1,568,000 after buying an additional 104 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its holdings in Mettler-Toledo International by 0.3% during the second quarter. Nomura Asset Management Co. Ltd. now owns 9,465 shares of the medical instruments supplier’s stock valued at $11,119,000 after acquiring an additional 31 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Mettler-Toledo International by 0.5% during the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock valued at $3,003,415,000 after acquiring an additional 13,342 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.94% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on MTD shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research note on Monday, December 15th. Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target for the company. Finally, Morgan Stanley reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $1,435.42.

Mettler-Toledo International Stock Down 1.2%

Shares of Mettler-Toledo International stock opened at $1,191.74 on Thursday. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,525.17. The business has a 50-day moving average price of $1,362.49 and a 200-day moving average price of $1,366.62. The firm has a market cap of $24.22 billion, a price-to-earnings ratio of 28.29, a PEG ratio of 2.53 and a beta of 1.43.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the previous year, the business earned $12.41 earnings per share. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.